Bumper Offer - Urjas oil Just @ Rs. 1
Metocard H 50 Tablet ER, a prescription drug, is manufactured in various forms such as Tablet. Other than this, Metocard H 50 Tablet ER has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Metocard H 50 Tablet ER. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Metocard H 50 Tablet ER include Slow heart rate (pulse). Some other side effects of Metocard H 50 Tablet ER have been listed ahead. Such side effects of Metocard H 50 Tablet ER normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Metocard H 50 Tablet ER's effect during pregnancy is Safe and Safe while nursing. Warnings related to Metocard H 50 Tablet ER's effects on the liver, heart and kidney, if any, have been listed below.
Metocard H 50 Tablet ER is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Asthma, Allergy are examples of such conditions. The section on Metocard H 50 Tablet ER contraindications lists all such conditions.
Drug interactions for Metocard H 50 Tablet ER have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Metocard H 50 Tablet ER is not safe while driving, and is is not addictive in nature.
Metocard H 50 Tablet ER is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Metocard H 50 Tablet ER is used -
Moderate
Mild
Common
Is the use of Metocard H 50 Tablet ER safe for pregnant women?
Pregnant women can take Metocard H safely.
Is the use of Metocard H 50 Tablet ER safe during breastfeeding?
Metocard H is safe for breastfeeding women.
What is the effect of Metocard H 50 Tablet ER on the Kidneys?
Metocard H rarely harms the kidneys.
What is the effect of Metocard H 50 Tablet ER on the Liver?
Very few cases of side effects of Metocard H on the liver have been reported.
What is the effect of Metocard H 50 Tablet ER on the Heart?
Very few cases of side effects of Metocard H on the heart have been reported.
Metocard H 50 Tablet ER should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Metocard H 50 Tablet ER unless your doctor advises you to do so -
Is this Metocard H 50 Tablet ER habit forming or addictive?
Forming a habit of Metocard H 50 Tablet ER has not been reported.
Interaction between Food and Metocard H 50 Tablet ER
Eating certain foods may increase the time it takes Metocard H 50 Tablet ER to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Metocard H 50 Tablet ER
Consult your doctor before consuming alcohol while taking Metocard H 50 Tablet ER as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
